1. Home
  2. AVIR vs LIEN Comparison

AVIR vs LIEN Comparison

Compare AVIR & LIEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVIR
  • LIEN
  • Stock Information
  • Founded
  • AVIR 2012
  • LIEN 2021
  • Country
  • AVIR United States
  • LIEN United States
  • Employees
  • AVIR N/A
  • LIEN N/A
  • Industry
  • AVIR Medicinal Chemicals and Botanical Products
  • LIEN
  • Sector
  • AVIR Health Care
  • LIEN
  • Exchange
  • AVIR Nasdaq
  • LIEN NYSE
  • Market Cap
  • AVIR 276.9M
  • LIEN 294.4M
  • IPO Year
  • AVIR 2020
  • LIEN 2022
  • Fundamental
  • Price
  • AVIR $3.36
  • LIEN $12.93
  • Analyst Decision
  • AVIR Hold
  • LIEN
  • Analyst Count
  • AVIR 1
  • LIEN 0
  • Target Price
  • AVIR $6.88
  • LIEN N/A
  • AVG Volume (30 Days)
  • AVIR 130.4K
  • LIEN 12.5K
  • Earning Date
  • AVIR 11-07-2024
  • LIEN 11-08-2024
  • Dividend Yield
  • AVIR N/A
  • LIEN 7.71%
  • EPS Growth
  • AVIR N/A
  • LIEN 5.69
  • EPS
  • AVIR N/A
  • LIEN 0.90
  • Revenue
  • AVIR N/A
  • LIEN $12,422,942.00
  • Revenue This Year
  • AVIR N/A
  • LIEN N/A
  • Revenue Next Year
  • AVIR N/A
  • LIEN N/A
  • P/E Ratio
  • AVIR N/A
  • LIEN $14.44
  • Revenue Growth
  • AVIR N/A
  • LIEN 44.81
  • 52 Week Low
  • AVIR $2.77
  • LIEN $7.29
  • 52 Week High
  • AVIR $4.60
  • LIEN $13.38
  • Technical
  • Relative Strength Index (RSI)
  • AVIR 44.61
  • LIEN N/A
  • Support Level
  • AVIR $3.22
  • LIEN N/A
  • Resistance Level
  • AVIR $3.41
  • LIEN N/A
  • Average True Range (ATR)
  • AVIR 0.13
  • LIEN 0.00
  • MACD
  • AVIR -0.01
  • LIEN 0.00
  • Stochastic Oscillator
  • AVIR 21.87
  • LIEN 0.00

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

About LIEN CHICAGO ATLANTIC BDC INC

Chicago Atlantic BDC Inc is a specialty finance company. The company's investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies.

Share on Social Networks: